Blog

Clinical Research Technology Comparison: Telemedicine Versus Video Conferencing for Healthcare
Telemedicine or telehealth solutions may not be new, but virtual video visits are becoming more common for communication between patients and healthcare providers thanks to COVID-19. In clinical trials, the application of telemedicine...

Clinical Research Sites Must Prioritize Technology Competency to Stay Competitive
Technology has infiltrated the clinical research space and is transforming the way research gets done. Predominant solutions across the healthcare and bioscience industries include electronic data capture (EDC), IVRS/registration systems, clinical trial management...

Impact Assessment of Decentralized Clinical Trials (DCT)
Clinical research sites continually strive to improve patient recruitment and engagement practices for clinical trials in an effort to provide sponsors with the critical data they need to bring new medications to market safely. In addition, it is an ongoing challenge...

Telemedicine Adoption is on the Rise
The rate of change across today’s clinical research landscape is breathtaking, especially for an industry that has historically been considered slow to adopt. As we face a world-wide pandemic the likes of which we’ve never seen before, our industry plays a critical...

VirTrial Selected as Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020
For the third year in a row VirTrial has been recognized in this prestigious competition. The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and...

Adapting Clinical Trial Protocol in Response to COVID-19
Based on recent SCRS survey data, a vast majority of research sites (58%) anticipate that COVID-19 will negatively affect their clinical trial enrollment and nearly half of respondents (47%) feel COVID-19 will have a negative effect on retention. With the number of...

FDA Recommends Clinical Trial Sponsors Consider Virtual Visits
The FDA recently released new guidance on clinical trials in the face of COVID-19. In their published report, FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic, they acknowledged that challenges may arise in ongoing trials. For...

Hybrid DCTs Reduce Dropout Rates in Long-Term Studies
Clinical studies are carefully designed to address the unique needs of not only the sponsor, but more importantly, the patients that commit to participate. Depending on the nature and severity of the condition, study lengths vary. A cardiovascular outcome trial...

Telemedicine in the Era of Coronavirus Disease
The Coronavirus Disease 2019 (COVID-19) is wreaking havoc around the globe. With a seemingly imminent pandemic on the horizon, healthcare organizations are rushing to prepare for the fallout. The Centers for Disease Control and Prevention warned that it expects the...

Decentralized Clinical Trials Enable Participation for Immobile Patients
Clinical trials require a significant commitment from patients, particularly in regard to travel time to research sites for regular visits. Consider the additional patient burden involved in clinical trials for patients with paralysis, dementia, or other conditions...

Request your free demo now!
Discover How We Can Help You To Improve Enrollment, Compliance and Retention